{
  "trial_id": "NCT03788057",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "steroids will be considered",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Criteria for discontinuation of participation in the study",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Loss of asthma control (treatment strategy: beta-mimetic temporarily, return to dose of ICS before reduction or further increase of treatment; in severe exacerbations,",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "The staff of the center has experience in the production of sputum induction in participants with asthma [Ci\u00f3\u0142kowski J, Mazurek H, Stasiowska B. Evaluation of step - down therapy from an inhaled steroid to montelukast in childhood asthma. Allergologia et immunopathologia (Madr.), Jul-Aug; 42 (4): 282-288].",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "The test will be performed in conditions ensuring patient safety, with the availability of an anaesthesiologist and anti-shock kit.",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "mild or moderate asthma with a stable course of at least 3 months: symptoms less than 4x per week,",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "use of SABA below 3x a week,",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "night awakening below 1x per week,",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "FEV1> 80% of predicted",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "no dose change in ICS or use of systemic steroids from 3 months",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "good adherence to treatment",
      "label": "met",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "infection or exacerbation of asthma requiring the use of systemic steroids (or changes in the dose of inhaled steroids) in the last 3 months before the study",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "other chronic lung diseases or general diseases affecting the respiratory system",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "tobacco smoking",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "FEV1 below 80% of the predicted value",
      "label": "not_met",
      "evidence": "none"
    }
  ],
  "notes": "The patient has mild or moderate asthma with a stable course, and meets most inclusion criteria. However, there is no clear indication of recent infection or exacerbation requiring systemic steroids.",
  "_meta": {
    "topic_id": "59",
    "trial_id": "NCT03788057",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}